SPI
18.404,03
PKT
-95,21
PKT
-0,51
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.09.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.09.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 09.09.19 | Roche overweight | Barclays Capital | |
| 09.09.19 | Nestlé overweight | Morgan Stanley | |
| 09.09.19 | Richemont buy | HSBC | |
| 09.09.19 | Swatch (I) buy | HSBC | |
| 09.09.19 | Novartis Hold | Deutsche Bank AG | |
| 09.09.19 | Givaudan buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.19 | Nestlé Hold | Deutsche Bank AG | |
| 06.09.19 | Holcim Hold | HSBC | |
| 06.09.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.09.19 | Clariant overweight | Barclays Capital | |
| 05.09.19 | Roche overweight | JP Morgan Chase & Co. | |
| 05.09.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 05.09.19 | ams-OSRAM overweight | Barclays Capital | |
| 05.09.19 | Holcim Hold | Deutsche Bank AG | |
| 05.09.19 | Novartis Underweight | Barclays Capital | |
| 05.09.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 05.09.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 03.09.19 | Swiss Re overweight | Barclays Capital | |
| 03.09.19 | Zurich Insurance Equal weight | Barclays Capital | |
| 03.09.19 | UBS Underweight | Barclays Capital | |
| 02.09.19 | Givaudan Underperform | Credit Suisse Group | |
| 02.09.19 | Zurich Insurance Neutral | UBS AG | |
| 02.09.19 | Givaudan Hold | Deutsche Bank AG | |
| 02.09.19 | Roche buy | Deutsche Bank AG | |
| 02.09.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 02.09.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 30.08.19 | UBS Hold | Deutsche Bank AG | |
| 30.08.19 | Novartis Hold | Deutsche Bank AG | |
| 30.08.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.08.19 | Swiss Re Sell | UBS AG | |
| 30.08.19 | UBS buy | Deutsche Bank AG | |
| 30.08.19 | UBS overweight | JP Morgan Chase & Co. | |
| 30.08.19 | Novartis buy | Jefferies & Company Inc. | |
| 29.08.19 | Roche buy | Jefferies & Company Inc. | |
| 29.08.19 | Novartis buy | Jefferies & Company Inc. | |
| 28.08.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.08.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.08.19 | BB Biotech neutral | Independent Research GmbH |